Departmental news
Womb lining test developed by WMS researchers offers miscarriage hope
A study led by WMS researchers has revealed an abnormal process in the womb lining as the explanation behind some preventable pregnancy loss, paving the way for new tests and treatments for some women who experience recurrent miscarriage.
Prehospital critical care teams less likely to attend cardiac arrest patients in deprived neighbourhoods, finds study
Prehospital critical care teams are less likely to attend cardiac arrest patients in more deprived neighbourhoods, according to a study led by Warwick Medical School.
New trial empowers women to choose how to deliver big babies
Published in The Lancet, findings from The Big Baby Trial - co-led by Prof Siobhan Quenby MBE of WMS - show early induction of labour of babies suspected to be large for their age in the womb can reduce complications at birth.
Safety and efficacy of a temperature-controlled ablation system for ventricular tachycardia: Results from the TRAC-VT study
TRAC-VT (isrctn.com identifier: ISRCTN84509594) was a prospective, multicentre, observational single-arm study enrolling patients at five hospitals in five European countries. The study evaluated the safety and efficacy of the DiamondTemp RF ablation system modulating power (based on real-time tissue temperature) in patients with sustained monomorphic VT and ICM/NICM. Headline results: Acute procedural success was 100% (95% CI, 91–100%). No primary safety endpoints were observed. Six-month follow-up was completed in 92% of patients with 81% (95% CI, 65–91%) freedom from sustained or treated VT.
Read the paper here.Link opens in a new window
Professor Janet Dunn leads pioneering Mammo-50 Trial
The Mammo-50 trial, the first major study to investigate the safest, most effective monitoring of women after surgery, has been published in The Lancet.
Professor Sian Taylor-Phillips to co-lead cutting edge trial to detect Breast Cancer using AI
The EDITH trial (‘Early Detection using Information Technology in Health’) is backed by £11 million of government support via the National Institute for Health and Care Research (NIHR). It is the latest example of how British scientists are transforming cancer care, building on the promising potential of cutting-edge innovations to tackle one of the UK’s biggest killers. Read the full news item here.
Leading UK study aiming to improve outcomes for patients with potentially life-threatening abnormal heart rhythms has successfully completed recruitment
A leading UK study aiming to improve outcomes for patients with potentially life-threatening abnormal heart rhythms (arrhythmias) has successfully completed recruitment at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust.